Last reviewed · How we verify
NCT06024668
Simulated Walking With Multiplexing Prism for Field Expansion in Monocular Vision
NA trial testing Multiplexing Prism in One Eye Blindness in 1 participant. Terminated before completion.
31 December 2024
Quick facts
| Lead sponsor | Massachusetts Eye and Ear Infirmary |
|---|---|
| Phase | NA |
| Status | Terminated |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | single group |
| Masking | none |
| Primary purpose | basic science |
| Enrollment | 1 |
| Start date | 4 August 2024 |
| Primary completion | 31 December 2024 |
| Estimated completion | 1 January 2025 |
| Sites | 1 location across United States |
Drugs / interventions tested
- Multiplexing Prism
Conditions studied
- One Eye Blindness — all drugs for One Eye Blindness →
- Blind Left Eye — all drugs for Blind Left Eye →
- Blind Right Eye — all drugs for Blind Right Eye →
Sponsor
Massachusetts Eye and Ear Infirmary — full company profile →
Who can join
16 and older, any sex, with One Eye Blindness or Blind Left Eye. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The investigators are developing an assistive device, known as multiplexing prism that expands the field of view for individuals with acquired monocular vision (loss of an eye). The investigators will test the efficacy of the prism in improving the detection of colliding pedestrians during a simulated walking task.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT06024668
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Multiplexing Prism
Trials testing the same drug.
- NCT06027216 — Multiplexing Prism Fitting for Field Expansion of Monocular Vision · NA · completed
Other Massachusetts Eye and Ear Infirmary trials
Trials by the same sponsor.
- NCT06926478 — Subconjunctival Humira for Boston Keratoprosthesis · Phase 1 · not yet recruiting
- NCT06425419 — The Safety and Efficacy of Intravitreal Topotecan for the Treatment of Proliferative Vitreoretinopathy · Phase 1 · not yet recruiting
- NCT07383701 — Lactiplantibacillus Plantarum 299v Probiotic Supplementation in Patients With Diabetic Macular Edema · Phase 2 · not yet recruiting
- NCT06688578 — Testing Effectiveness of a Stochastic Noise Stimulator to Immediately Improve Balance and Gait · NA · recruiting
- NCT06753916 — ExCrossV Multi Site Trial for Vascularized High Risk Keratoplasty · Phase 2 · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06024668 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Massachusetts Eye and Ear Infirmary
- Last refreshed: 14 April 2026
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06024668.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing